DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MG1B310

Real-time Bid/Ask 10:34:20 2024-06-12 EDT
159.23 EUR / 159.31 EUR -0.87% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+1.70%
1 month+1.14%
Date Price Change
24-06-12 160.1 -0.35%
24-06-11 160.7 +0.14%
24-06-10 160.4 +0.48%
24-06-07 159.7 +0.71%
24-06-06 158.6 -0.11%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 05:48 am

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG1B31
ISINDE000MG1B310
Date issued 2024-04-02
Maturity 2025-03-21 (282 Days)
Parity 1 : 1
Emission price 159.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 161.1
Lowest since issue 155.5
Spread 0.08
Spread %0.05%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
234.9 USD
Average target price
278.7 USD
Spread / Average Target
+18.62%
Consensus